Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A new approach to personalized medicine is resulting in phase I and phase II clinical trials that rely on extensive, hands-on investigator and clinical research (CR) staff training, and these types of studies are creating both new challenges and opportunities for North American CR sites.

Personalized immunotherapy research leads to more complex clinical trials